Short-term blinatumomab for B-cell acute lymphoblastic leukemia pediatric patients results in measurable residual disease clearance. - Xue C; Wu C; Zhang Y; Yang W; Zou Y; Guo Y; Ma Y; Chen Y; Chen X; Zhu X; Zhang L (Annals of hematology, 2026)